This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Givner, L. B.
Right arrow Articles by Kaplan, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Givner, L. B.
Right arrow Articles by Kaplan, S. L.
Related Collections
Right arrow Infectious Disease & Immunity

PEDIATRICS Vol. 106 No. 5 November 2000, p. e61

ELECTRONIC ARTICLE:
Pneumococcal Facial Cellulitis in Children

Received Mar 23, 2000; accepted Jun 8, 2000.

Laurence B. Givner*, Edward O. Mason Jr.Dagger , William J. Barson§, Tina Q. Tanparallel , Ellen R. Wald, Gordon E. Schutze#, Kwang Sik Kim**, John S. BradleyDagger Dagger , Ram Yogevparallel , and Sheldon L. KaplanDagger

From the * Department of Pediatrics, Wake Forest University School of Medicine, Winston-Salem, North Carolina; Dagger  Department of Pediatrics, Baylor College of Medicine, Houston, Texas; § Department of Pediatrics, Ohio State University College of Medicine, Columbus, Ohio; parallel  Department of Pediatrics, Northwestern University Medical School, Chicago, Illinois;  Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; # Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, Arkansas; ** Department of Pediatrics, University of Southern California School of Medicine, Los Angeles, California; and Dagger Dagger  Department of Pediatrics, Children's Hospital-San Diego, San Diego, California.

Objective.  To review the epidemiology and clinical course of facial cellulitis attributable to Streptococcus pneumoniae in children.

Design.  Cases were reviewed retrospectively at 8 children's hospitals in the United States for the period of September 1993 through December 1998.

Results.  We identified 52 cases of pneumococcal facial cellulitis (45 periorbital and 7 buccal). Ninety-two percent of patients were <36 months old. Most were previously healthy; among the 6 with underlying disease were the only 2 patients with bilateral facial cellulitis. Fever (temperature: >= 100.5°F) and leukocytosis (white blood cell count: >15 000/mm3) were noted at presentation in 78% and 82%, respectively. Two of 15 patients who underwent lumbar puncture had cerebrospinal fluid with mild pleocytosis, which was culture-negative. All patients had blood cultures positive for S pneumoniae. Serotypes 14 and 6B accounted for 53% and 27% of isolates, respectively. Overall, 16% and 4% were nonsusceptible to penicillin and ceftriaxone, respectively. Such isolates did not seem to cause disease that was either more severe or more refractory to therapy than that attributable to penicillin-susceptible isolates. Overall, the patients did well; one third were treated as outpatients.

Conclusions.  Pneumococcal facial cellulitis occurs primarily in young children (<36 months of age) who are at risk for pneumococcal bacteremia. They present with fever and leukocytosis. Response to therapy is generally good in those with disease attributable to penicillin-susceptible or -nonsusceptible S pneumoniae. Ninety-six percent of the serotypes causing facial cellulitis in this series are included in the heptavalent-conjugated pneumococcal vaccine recently licensed in the United States.  Key words:  Streptococcus pneumoniae, cellulitis, antibiotic resistance.